Advances in nanomedicine, including early cancer detection, targeted drug delivery, and
personalized approaches to cancer treatment are on the rise. For example, targeted drug …

Nano-drug delivery strategies have been highlighted in cancer treatment, and much effort
has been made in the optimization of bioavailability, biocompatibility, pharmacokinetics …

Advances in nanomedicine have become indispensable for targeted drug delivery, early
detection, and increasingly personalized approaches to cancer treatment. Nanoparticle …

Conventional drug delivery systems for solid tumors are composed of a nano-carrier that
releases its therapeutic load. These two-stage nanoparticles utilize the enhanced …

Nonspecific distribution and uncontrollable release of drugs in conventional drug delivery
systems (CDDSs) have led to the development of smart nanocarrier-based drug delivery …

Nano-based drug delivery systems hold significant promise for cancer therapies. Presently,
the poor accumulation of drug-carrying nanoparticles in tumors has limited their success. In …

To achieve the promise of stimuli-responsive drug delivery systems for the treatment of
cancer, they should (1) avoid premature clearance;(2) accumulate in tumors and undergo …

Nanoparticles have been widely used in tumor targeted drug delivery, while the antitumor
effects are not always satisfactory due to the limited penetration and retention. As we all …

Although nanomedicine has been highly investigated for cancer treatment over the past
decades, only a few nanomedicines are currently approved and in the market; making this …

Cancer is the second largest cause of death worldwide with the number of new cancer
cases predicted to grow significantly in the next decades. Biotechnology and medicine can …